Eculizumab treatment for paroxysmal nocturnal haemoglobinuria in a patient with recurrent simultaneous multivessel coronary stent thrombosis

被引:1
|
作者
De Maria, Giovanni Luigi [1 ]
Sarwar, Rizwan [1 ]
Banning, Adrian P. [1 ]
机构
[1] Oxford Univ Hosp, Oxford Heart Ctr, Oxford, England
来源
关键词
D O I
10.1093/omcr/omu063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe a case of recurrent multivessel coronary stent thrombosis in the absence of the typical hallmarks of this phenomenon: (i) discontinuation or poor compliance with double antiplatelet therapy; (ii) stent malapposition and (iii) stent underexpansion. In this case, the recurrence of stent thrombosis was indeed manifestation of a more complex underlying disease, and eventually allowed the clinicians to come to the final diagnosis of paroxysmal nocturnal haemoglobinuria.
引用
收藏
页码:167 / 169
页数:3
相关论文
共 50 条
  • [1] With paroxysmal nocturnal haemoglobinuria and treatment with eculizumab
    Tomas Algado, Jose
    Luque, Rafael
    Nunez, Ramiro
    Sanchez, Berta
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2012, 30 (02): : 109 - 110
  • [2] Eculizumab in paroxysmal nocturnal haemoglobinuria
    Escudero-Jimenez, Angel
    Jesus Esteban-Mensua, Maria
    Lopez-Briz, Eduardo
    Jarque-Ramos, Isidro
    Borrell-Garcia, Carmela
    Luis Poveda-Andres, Jose
    [J]. EJHP PRACTICE, 2011, 17 (01): : 31 - 35
  • [3] Eculizumab in paroxysmal nocturnal haemoglobinuria
    Charneski, Lisa
    Patel, Priti N.
    [J]. DRUGS, 2008, 68 (10) : 1341 - 1346
  • [4] Eculizumab for paroxysmal nocturnal haemoglobinuria
    Parker, Charles
    [J]. LANCET, 2009, 373 (9665): : 759 - 767
  • [5] Eculizumab in Paroxysmal Nocturnal Haemoglobinuria
    Lisa Charneski
    Priti N. Patel
    [J]. Drugs, 2008, 68 : 1341 - 1346
  • [6] A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab
    Schutgens, Roger E. G.
    Pruissen-Peeters, Kim A. B. M.
    Muus, Petra
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (02) : 383 - 385
  • [7] The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal haemoglobinuria
    Hillmen, P.
    Hill, A.
    Muus, P.
    Duhrsen, U.
    Risitano, A. M.
    Schubert, J.
    Young, N. S.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Socie, G.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Luzzatto, L.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 : 34 - 34
  • [8] Disseminated gonococcal infection in a patient with paroxysmal nocturnal haemoglobinuria receiving eculizumab
    Niitsuma-Sugaya, Ikumi
    Kanamori, Hajime
    Ichikawa, Satoshi
    Fukuhara, Noriko
    Seike, Issei
    Takei, Kentaro
    Baba, Hiroaki
    Oshima, Kengo
    Aoyagi, Tetsuji
    Harigae, Hideo
    Tokuda, Koichi
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 741 - 741
  • [9] Eculizumab (Soliris®): a promising treatment of haemolytic anaemia in paroxysmal nocturnal haemoglobinuria
    Waldner, B.
    [J]. BONE MARROW TRANSPLANTATION, 2009, 43 : S362 - S362
  • [10] Eculizumab A Review of its Use in Paroxysmal Nocturnal Haemoglobinuria
    McKeage, Kate
    [J]. DRUGS, 2011, 71 (17) : 2327 - 2345